- Comp & Benefits
- Work/Life Balance
- Senior Management
- Culture & Values
- Career Opportunities
I have been working at Affymax full-time (less than an year)Pros
People have great communication and collaborative minds. there are no barriers between departments and everyone sincerely wants to have a great quality product.Cons
There is nothing really to say. this has been one of the best places I have worked at. I wish it was the same at every company.Advice to ManagementAdvice
Management has been great at supporting personal growth and communication. My director is flexible and reasonable.RecommendsNeutral OutlookNo opinion of CEO
Getting an Interview
Getting an Interview
- Application Details
I applied through a recruiter. The process took 2+ weeks – interviewed at Affymax in November 2012.Interview Details
Initially the process was well organized with a structured schedule for the interview and the folks I spoke on the phone were articulate, interesting and reasonable.
On the interview day, met the Exec Director, followed by the Finance directors, Project Management and the current Manager of IT. Here's the deal - the place is in a need for a major overhaul. They've recently implemented a software package that has more issues than you can count on all your fingers and toes, many times over. The job wasn't' looking too appetizing at that point, but I kept my interest alive through the process.
What I found most unprofessional was that I never heard from the company after the interview. No calls, no emails indicating what they had decided etc.. So watch out for this.Interview Questions
No OfferNegative ExperienceEasy Interview
- The IT manager I interviewed me, asked why I wanted this job and that perhaps I should look for a VP job at another company..huh ! Answer Question
Let us know if we're missing any workplace or industry recognition –
Affymax is designing peptides to give red blood cells a pep talk. The biotechnology firm is researching and developing possible drugs based upon these biological process regulators. Its leading drug candidate, Hematide, is an erythropoietin (EPO) mimetic, designed to stimulate red blood cell production, like EPO itself. Hematide is being investigated in late stage clinical trials as a possible treatment for anemia caused by chronic renal failure and chemotherapy. Affymax believes Hematide will be cheaper and longer lasting than the EPO stimulants currently used on dialysis...